The Asian Scientist 100
Yi Yang
Institution
University of Hong Kong
Country
Hong Kong
Field
Physics
Yang received the 2024 Croucher Tak Wah Mak Innovation Award for his research aiming to realise strong free-electron-light interaction by interfacing slow nonrelativistic electrons with judiciously designed photonic environments.
(Photo: University of Hong Kong)
AWARDS
- 2024 Croucher Tak Wah Mak Innovation Award
Related articles
Taiwanese Doctors Show Gene Screening Prevents Drug Reactions
Taiwanese researchers have used genetic screening to prevent two potentially fatal drug-induced syndromes.
Sinovac Reports PhIII Trial Results For HFMD Vaccine Candidate
Chinese vaccine provider Sinovac Biotech Ltd. has completed a Phase III clinical trial on its Enterovirus 71 vaccine against hand, foot, and mouth disease.
Blurring The Boundaries In Science: GYSS@one-north
At the Global Young Scientist Summit 2013, a panel of Nobel laureates from various disciplines discussed the difficulties of multidisciplinary research.
Antimicrobial Hydrogel To Fight Drug-Resistant Biofilms
Researchers have designed a new antimicrobial hydrogel that can break through diseased biofilms and eradicate drug-resistant bacteria upon contact.
China, France Collaborate On Infectious Disease Research
The Chinese Academy of Sciences and France have established a Sino-France biosafety laboratory in Wuhan, Hubei Province.
Jiaolong Submersible Sets Off On Historic 5,000 Meter Dive
China's manned deep-diving submersible Jiaolong (蛟龙) has left a port in Jiangyin, Jiangsu province for a 5,000 meter dive in the Pacific Ocean.
South Korean Study Suggests That Autism Is More Prevalent Than Believed
Researchers estimate that about 1 in 38 South Korean children have autism, a figure which is three times higher than a 2006 US study.
A Gene That Both Causes Leukemia And Fights Liver Cancer
Researchers say a human gene implicated in the development of leukemia also acts to prevent cancer of the liver.
IBN And IBM Fight Superbugs With Polymeric Nanoparticles
Scientists at A*STAR and IBM Research – Almaden have developed biodegradable polymer nanoparticles that combat drug-resistant superbugs.